Carregant...
Neuroimaging Biomarkers for Alzheimer’s Disease
Currently, over five million Americans suffer with Alzheimer’s disease (AD). In the absence of a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical research is to establish indicators of AD during the preclinical stage (i.e. biomarkers) allowing for early diagnos...
Guardat en:
| Publicat a: | Mol Neurodegener |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555939/ https://ncbi.nlm.nih.gov/pubmed/31174557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-019-0325-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|